1 min read
Chief Medical Officer Summit -CMO 360°
Meet the Veristat team at Booth #3, April 17th and 18th in Boston
The Science-First CRO™ and Consultancy Ready to...
2 min read
Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at 12pm ET, “Putting Science First in Rare Disease Studies”.
Listen to our experts and hear firsthand how Veristat’s track record as a leading rare disease CRO has powered success for our sponsors. We’ve directly supported over 350 rare disease clinical trials and nearly 40 marketing applications in the last five years alone.
The presentation is filled with actionable insights, with ample time allowed for your questions to be answered. Don't miss this opportunity to connect with our Experts and learn how Veristat is making a difference in the lives of patients with rare and ultra-rare diseases.
- Thursday, April 25 at 12:00 PM
- Topic: Putting Science First in Rare Disease Studies
Meet the Speakers
Robin Bliss,PhD
Vice President, Consulting, Veristat
Robin joined Veristat in 2011 and is currently Vice President, Strategic Consulting. In her role, Robin oversees and executes Strategic Clinical Development Consulting, collaborating with Regulatory Consulting, Clinical and Medical Consulting and Statistical Consulting.
Robin has a passion for cross- functional collaboration and problem solving, delivering with her colleagues approaches for the planning and execution of clinical trials and marketing applications. A statistically-oriented professional with 15+ years’ experience in clinical biostatistics, Robin is highly experienced in planning and implementing complex study protocols and designs including adaptive design as well as in planning and executing study analysis, regulatory submissions, and providing statistical and strategy representation at regulatory agency meetings. Prior to joining Veristat, Robin worked with Brigham and Women's Hospital Orthopedic and Arthritis Center for Outcomes Research and with Boston University School of Public Health Environmental Health Department.
Robin earned her PhD and MA in Biostatistics from Boston University and her BA in Mathematics from Williams College in Williamstown, MA. When not at work, you can find Robin outside, staying active with her family.
Robin has a passion for cross- functional collaboration and problem solving, delivering with her colleagues approaches for the planning and execution of clinical trials and marketing applications. A statistically-oriented professional with 15+ years’ experience in clinical biostatistics, Robin is highly experienced in planning and implementing complex study protocols and designs including adaptive design as well as in planning and executing study analysis, regulatory submissions, and providing statistical and strategy representation at regulatory agency meetings. Prior to joining Veristat, Robin worked with Brigham and Women's Hospital Orthopedic and Arthritis Center for Outcomes Research and with Boston University School of Public Health Environmental Health Department.
Robin earned her PhD and MA in Biostatistics from Boston University and her BA in Mathematics from Williams College in Williamstown, MA. When not at work, you can find Robin outside, staying active with her family.
Anthy Tsatoumas
Manager, Project Management, Veristat
Anthy joined Veristat in 2017 and is currently the Manager of Project Management. In her role, Anthy oversees Veristat’s Global Project team responsible for executing clients’ Phase I-IV clinical trial and regulatory submission projects, orchestrating deliverables across data management, biostatistics, programming, medical writing, and clinical trial monitoring in accordance with all applicable regulations and guidelines.
Guided by a client’s business requirements and good clinical research practices, Anthy brings a passion for quality clinical research, possessing more than 25 years of experience in the field, holding roles of increasing responsibility throughout her career as Project Manager, Quality Standards Manager, QC Auditor, CRA, and Clinical Research Coordinator, maintaining a commitment to decreasing cycle times and costs.
Prior to Veristat, Anthy worked at Pfizer for 10 years in Project Management and Quality Standards Management.
Anthy holds a Bachelor of Science, Anatomical Sciences, from McGill University, Montréal Canada. She has been an ad hoc volunteer for 17 years in the neonatology department at Montreal Children's Hospital, supporting projects related to extremely premature infant birth.
Guided by a client’s business requirements and good clinical research practices, Anthy brings a passion for quality clinical research, possessing more than 25 years of experience in the field, holding roles of increasing responsibility throughout her career as Project Manager, Quality Standards Manager, QC Auditor, CRA, and Clinical Research Coordinator, maintaining a commitment to decreasing cycle times and costs.
Prior to Veristat, Anthy worked at Pfizer for 10 years in Project Management and Quality Standards Management.
Anthy holds a Bachelor of Science, Anatomical Sciences, from McGill University, Montréal Canada. She has been an ad hoc volunteer for 17 years in the neonatology department at Montreal Children's Hospital, supporting projects related to extremely premature infant birth.
Veristat at the WODC Conference
Find us at Booth 619 where we invite you to stop by and discover more about what makes Veristat a distinguished name in the clinical research industry. Our team will share insights and answer questions you might have about our Science-First approach that delivers several benefits to sponsors including the right design, reliable trial execution, and successful study completion to support rapid approval.
Schedule A Meeting
You can arrange a meeting by completing the form on the right side of this page. Discover how we can assist you in progressing your upcoming clinical trial or regulatory submission towards a successful outcome or explore our wide range of capabilities.
Conference Details
Website: WODC Congress USA 2024